Oncolytics Biotech Inc. - Common Shares (NQ: ONCY )
0.7672
-0.0049
(-0.63%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Headline News about Oncolytics Biotech Inc. - Common Shares
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
A Preview Of Oncolytics Biotech's Earnings
March 06, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Earnings Scheduled For November 12, 2024
November 12, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Oncolytics Biotech
November 11, 2024
Via Benzinga
![](https://public.newsdirect.com/975078195/9gSZ9R30.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Recap: Oncolytics Biotech Q4 Earnings
March 07, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Oncolytics Biotech's Earnings Outlook
November 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Oncolytics Biotech's Earnings: A Preview
August 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
5 Analysts Have This to Say About Oncolytics Biotech
June 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_8813.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Oncolytics Biotech
May 26, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Oncolytics Biotech: Q1 Earnings Insights
May 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](/next-assets/images/schema-image-default.png)
Oncolytics Biotech's Earnings: A Preview
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Oncolytics Biotech's Earnings: A Preview
March 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8354.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/22/avid_bioservices_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/26/hibbett_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_138.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/01/image33.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1403.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/01/image-dollar_general_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2580.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/09/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5067.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free